Ad is loading...
MCVAX
Price
$11.83
Change
-$0.08 (-0.67%)
Updated
Nov 15 closing price
VMVAX
Price
$87.94
Change
-$0.20 (-0.23%)
Updated
Nov 15 closing price
Ad is loading...

MCVAX vs VMVAX

Header iconMCVAX vs VMVAX Comparison
Open Charts MCVAX vs VMVAXBanner chart's image
Transamerica Mid Cap Value Opps A
Price$11.83
Change-$0.08 (-0.67%)
VolumeN/A
CapitalizationN/A
Vanguard Mid-Cap Value Index Admiral
Price$87.94
Change-$0.20 (-0.23%)
VolumeN/A
CapitalizationN/A
MCVAX vs VMVAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
MCVAX vs. VMVAX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MCVAX is a Buy and VMVAX is a Buy.

FUNDAMENTALS
Fundamentals
VMVAX has more cash in the bank: 30.9B vs. MCVAX (1.23B). VMVAX pays higher dividends than MCVAX: VMVAX (2.14) vs MCVAX (0.52). MCVAX was incepted earlier than VMVAX: MCVAX (11 years) vs VMVAX (13 years). MCVAX is a more actively managed with annual turnover of: 44.00 vs. VMVAX (22.00). MCVAX has a lower initial minimum investment than VMVAX: MCVAX (1000) vs VMVAX (3000). VMVAX annual gain was more profitable for investors over the last year : 27.09 vs. MCVAX (12.67). VMVAX return over 5 years is better than : 47.45 vs. MCVAX (1.29).
MCVAXVMVAXMCVAX / VMVAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence11 years13 years-
Gain YTD9.03217.35552%
Front LoadN/AN/A-
Min. Initial Investment1000300033%
Min. Initial Investment IRAN/AN/A-
Net Assets1.23B30.9B4%
Annual Yield % from dividends0.522.1425%
Returns for 1 year12.6727.0947%
Returns for 3 years-21.3513.54-158%
Returns for 5 years1.2947.453%
Returns for 10 years12.8696.8413%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HKD2.74-0.09
-3.18%
AMTD Digital
SPB88.22-5.64
-6.01%
Spectrum Brands Holdings
IPG27.09-2.11
-7.23%
Interpublic Group of Companies (The)
SBFM2.35-0.23
-8.75%
Sunshine Biopharma Inc
IKT2.05-0.31
-13.14%
Inhibikase Therapeutics